Merck Animal Health
Vista 5 VL5 SQ
Vista 5 VL5 SQ
VISTA® 5 VL5 SQ is for the vaccination of healthy cows and heifers prior to breeding as an aid in the reduction of abortion due to infectious bovine rhinotracheitis (IBR); as an aid in the prevention of fetal infection, including persistently infected calves caused by bovine virus diarrhea virus (BVD) (Types 1 & 2). Reproductive Duration of Immunity (DOI) has been demonstrated to be at least 217 days for IBR and at least 206 days for BVD (Types 1 & 2). In addition, it can be used as an aid in the prevention of disease caused by IBR, BVD (Type 2); and bovine respiratory syncytial virus (BRSV), as an aid in the control of disease caused by BVD (Type 1), and parainfluenza3 virus (PI3), as an aid in reducing infertility (reproductive disease caused by Campylobacter fetus), and as an aid in preventing leptospirosis (caused by Leptospira canicola, L. grippotyphosa, L. hardjo - including the L. borgpetersenii serovar hardjo bovis, L. icterohaemorrhagiae, and L. pomona) and as an aid in prevention of urinary shedding of hardjo organisms.
Respiratory Duration of Immunity (DOI) has been demonstrated to be at least 182 days for IBR, at least 206 days for BVD (Type 1), and at least 200 days for BVD (Type 2). Safe for use in pregnant heifers and cows or calves nursing pregnant cows provided the cows and heifers in the herd are vaccinated prior to breeding, within the previous 12 months, with any of the modified-live IBR and BVD containing vaccine(s) in this product line.
Modified-live virus and bacterin combination for the vaccination of healthy cows and heifers, 6 months of age or older, prior to breeding, as an aid in the control of abortions caused by IBR; an aid in the prevention of persistently infected calves caused by BVD 1 and 2; an aid in the control of respiratory disease caused by IBR, BVD 1 and 2, PI3 and BRSV; an aid in reducing infertility caused by Campylobacter fetus (Vibrio); an aid in preventing the 5 most common strains of Lepto, including L. borgpetersenii serovar hardjo-bovis, and an aid in prevention of urinary shedding of L. hardjo organisms. Duration of immunity has been demonstrated to be at least 182 days for IBR and at least 200 days for BVD 1 and 2.
Dosage: 2 ml subcut. Revaccinate annually. Safe for use in pregnant heifers and cows or calves nursing pregnant cows provided the cows and heifers in the herd are vaccinated prior to breeding, within the previous 12 months, with any of the modified live IBR and BVD containing vaccines in this product line. 21 day slaughter withdrawal.
Manufacturer and/or Label Information
Manufacturer and/or Label Information
GENERAL INFORMATION: This product has been shown to be effective for the vaccination of healthy horses, cattle, sheep, goats, and swine against tetanus. This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity is unknown. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.
Safety in pregnant animals is unknown.
Tetanus Toxoid is prepared by detoxifying tetanus toxin in such a manner as to allow the antigenic properties to remain intact. Product is purified, concentrated and adjuvanted to provide a low dose effective immunizing agent.
Each serial is tested for purity, safety, and potency in accordance with USDA requirements.
Tetanus is caused by a neurotoxin produced by growth of Clostridium tetani, an anaerobic (lives without air) micro-organism, in necrotic tissue. Affected animals become stiff, have difficulty swallowing, and have an increased pulse rate. Breathing is labored. Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw.
Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw. Thus, the term “lockjaw” is often used. Legs and tail are often stiff with abdominal muscles contracted. Tetanus stricken animals may be unusually sensitive to light and heat. Temperature of the animal generally remains normal, elevating only shortly before death.
Protective antibody levels usually occur about two weeks after the second injection of the primary immunization series. In contrast, administration of Tetanus Antitoxin is recommended for immediate, emergency, passive treatment of exposed animals with unknown vaccination history or with signs of tetanus infection.
DIRECTIONS: Do not vaccinate within 21 days before slaughter. Store at 2-8° C. Do not freeze. Do not mix with other products. Shake well before use. Use entire contents when first opened.
PRECAUTIONS: A transitory local reaction may occur at injection site. Anaphylactoid reaction may occur following administration of products of this nature. If noted, administer adrenalin or equivalent. In case of human exposure, consult a physician.
DOSAGE & ADMINISTRATION: For primary immunization, two doses should be administered subcutaneously or intramuscularly approximately 30 days apart. Use intramuscularly for horses as local reactions are more likely to occur if injected subcutaneously.
Horses: 1 ml IM
Cattle: 1 ml SC or IM
Sheep, Goats, Swine: 0.5 ml SC or IM
Historically, annual single dose revaccination has been recommended. Contact veterinarian for advice.
OTHER INFORMATION: Contains thimerosal and formalin as preservatives. Tetanus Toxoid Concentrate is available in single dose size packaged 10 vials to the carton, and in 10 dose vials.
THE PEAK OF QUALITY SINCE 1923
VLN: 188 / PCN: 8601.00
COLORADO SERUM COMPANY, 4950 York Street, Denver, Colorado 80216
Contact us for information on other Colorado Serum Company products. Fine Veterinary Products since 1923.
FOR VETERINARY USE ONLY
10 - 1 ml vials
10 - 1 dose vials